Current location: Home > NEWS > Industry news
NEWS
PRODUCTS
Summary of updates on ovarian cancer indications for PARP inhibitors
11-16
2023
As the weather gradually turns cooler, do tumors also respond to temperature changes?
11-03
The 2023 FIGO staging of endometrial cancer includes molecular classification
10-20
Moboxetinib and sotoraxib have suffered setbacks one after another. What are the primary endpoints and secondary endpoints of clinical trials of anti-tumor drugs?
10-11